世界の特殊注射液市場インサイト及び予測(マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液)

【英語タイトル】Global Special Injection Market Insights, Forecast to 2028

QYResearchが出版した調査資料(QY22DE18451)・商品コード:QY22DE18451
・発行会社(調査会社):QYResearch
・発行日:2022年12月
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、特殊注射液の世界市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
特殊注射液のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
特殊注射液の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
特殊注射液のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面に関しては、当レポートは2017年から2022年までの特殊注射液の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面に関しては、当レポートは2017年から2022年までの地域別、企業別、種類別、用途別の特殊注射液の売上および2028年までの予測に焦点を当てています。

特殊注射液のグローバル主要企業には、Hengrui、CSPC、Luye Pharma、Livzon、Fudan Zhangjiang、Takeda、Alkemes、Novartis、Ipsen、Sundocなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

特殊注射液市場は、種類と用途によって区分されます。世界の特殊注射液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液

【用途別セグメント】
悪性腫瘍治療、糖尿病治療、統合失調症治療、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 特殊注射液製品概要
- 種類別市場(マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液)
- 用途別市場(悪性腫瘍治療、糖尿病治療、統合失調症治療、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の特殊注射液販売量予測2017-2028
- 世界の特殊注射液売上予測2017-2028
- 特殊注射液の地域別販売量
- 特殊注射液の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別特殊注射液販売量
- 主要メーカー別特殊注射液売上
- 主要メーカー別特殊注射液価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液)
- 特殊注射液の種類別販売量
- 特殊注射液の種類別売上
- 特殊注射液の種類別価格
・用途別市場規模(悪性腫瘍治療、糖尿病治療、統合失調症治療、その他)
- 特殊注射液の用途別販売量
- 特殊注射液の用途別売上
- 特殊注射液の用途別価格
・北米市場
- 北米の特殊注射液市場規模(種類別、用途別)
- 主要国別の特殊注射液市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの特殊注射液市場規模(種類別、用途別)
- 主要国別の特殊注射液市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の特殊注射液市場規模(種類別、用途別)
- 主要国別の特殊注射液市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の特殊注射液市場規模(種類別、用途別)
- 主要国別の特殊注射液市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの特殊注射液市場規模(種類別、用途別)
- 主要国別の特殊注射液市場規模(トルコ、サウジアラビア)
・企業情報
Hengrui、CSPC、Luye Pharma、Livzon、Fudan Zhangjiang、Takeda、Alkemes、Novartis、Ipsen、Sundoc
・産業チェーン及び販売チャネル分析
- 特殊注射液の産業チェーン分析
- 特殊注射液の原材料
- 特殊注射液の生産プロセス
- 特殊注射液の販売及びマーケティング
- 特殊注射液の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 特殊注射液の産業動向
- 特殊注射液のマーケットドライバー
- 特殊注射液の課題
- 特殊注射液の阻害要因
・主な調査結果

Special injections are a class of complex drug delivery systems, including microspheres, liposomes, microemulsions, and suspension injections (nanoparticles, nanocrystals). Special injections have unique clinical advantages, and have the characteristics of high technical barriers and high added value, which can avoid homogeneous competition among enterprises to a certain extent. Release injection, favored by domestic enterprise developers.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Special Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Special Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Special Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Special Injection include Hengrui, CSPC, Luye Pharma, Livzon, Fudan Zhangjiang, Takeda, Alkemes, Novartis and Ipsen, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Special Injection manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Special Injection market. Further, it explains the major drivers and regional dynamics of the global Special Injection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hengrui
CSPC
Luye Pharma
Livzon
Fudan Zhangjiang
Takeda
Alkemes
Novartis
Ipsen
Sundoc
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Special Injection Segment by Type
Microsphere Injection
Liposome Injection
Microemulsion Injection
Suspension Injection
Special Injection Segment by Application
Malignant Tumor Treatment
Diabetes Treatment
Schizophrenia Treatment
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Special Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Special Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Special Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Special Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Special Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Special Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Special Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hengrui, CSPC, Luye Pharma, Livzon, Fudan Zhangjiang, Takeda, Alkemes, Novartis and Ipsen, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Special Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Special Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Special Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Study Coverage
1.1 Special Injection Product Introduction
1.2 Market by Type
1.2.1 Global Special Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microsphere Injection
1.2.3 Liposome Injection
1.2.4 Microemulsion Injection
1.2.5 Suspension Injection
1.3 Market by Application
1.3.1 Global Special Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Malignant Tumor Treatment
1.3.3 Diabetes Treatment
1.3.4 Schizophrenia Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Special Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Special Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Special Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Special Injection Sales by Region
2.4.1 Global Special Injection Sales by Region (2017-2022)
2.4.2 Global Sales Special Injection by Region (2023-2028)
2.5 Global Special Injection Revenue by Region
2.5.1 Global Special Injection Revenue by Region (2017-2022)
2.5.2 Global Special Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Special Injection Sales by Manufacturers
3.1.1 Global Top Special Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Special Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Special Injection in 2021
3.2 Global Special Injection Revenue by Manufacturers
3.2.1 Global Special Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Special Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Special Injection Revenue in 2021
3.3 Global Special Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Special Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Special Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Special Injection Sales by Type
4.1.1 Global Special Injection Historical Sales by Type (2017-2022)
4.1.2 Global Special Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Special Injection Sales Market Share by Type (2017-2028)
4.2 Global Special Injection Revenue by Type
4.2.1 Global Special Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Special Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Special Injection Revenue Market Share by Type (2017-2028)
4.3 Global Special Injection Price by Type
4.3.1 Global Special Injection Price by Type (2017-2022)
4.3.2 Global Special Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Special Injection Sales by Application
5.1.1 Global Special Injection Historical Sales by Application (2017-2022)
5.1.2 Global Special Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Special Injection Sales Market Share by Application (2017-2028)
5.2 Global Special Injection Revenue by Application
5.2.1 Global Special Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Special Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Special Injection Revenue Market Share by Application (2017-2028)
5.3 Global Special Injection Price by Application
5.3.1 Global Special Injection Price by Application (2017-2022)
5.3.2 Global Special Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Special Injection Market Size by Type
6.1.1 North America Special Injection Sales by Type (2017-2028)
6.1.2 North America Special Injection Revenue by Type (2017-2028)
6.2 North America Special Injection Market Size by Application
6.2.1 North America Special Injection Sales by Application (2017-2028)
6.2.2 North America Special Injection Revenue by Application (2017-2028)
6.3 North America Special Injection Market Size by Country
6.3.1 North America Special Injection Sales by Country (2017-2028)
6.3.2 North America Special Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Special Injection Market Size by Type
7.1.1 Europe Special Injection Sales by Type (2017-2028)
7.1.2 Europe Special Injection Revenue by Type (2017-2028)
7.2 Europe Special Injection Market Size by Application
7.2.1 Europe Special Injection Sales by Application (2017-2028)
7.2.2 Europe Special Injection Revenue by Application (2017-2028)
7.3 Europe Special Injection Market Size by Country
7.3.1 Europe Special Injection Sales by Country (2017-2028)
7.3.2 Europe Special Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Special Injection Market Size by Type
8.1.1 Asia Pacific Special Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Special Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Special Injection Market Size by Application
8.2.1 Asia Pacific Special Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Special Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Special Injection Market Size by Region
8.3.1 Asia Pacific Special Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Special Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Special Injection Market Size by Type
9.1.1 Latin America Special Injection Sales by Type (2017-2028)
9.1.2 Latin America Special Injection Revenue by Type (2017-2028)
9.2 Latin America Special Injection Market Size by Application
9.2.1 Latin America Special Injection Sales by Application (2017-2028)
9.2.2 Latin America Special Injection Revenue by Application (2017-2028)
9.3 Latin America Special Injection Market Size by Country
9.3.1 Latin America Special Injection Sales by Country (2017-2028)
9.3.2 Latin America Special Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Special Injection Market Size by Type
10.1.1 Middle East and Africa Special Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Special Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Special Injection Market Size by Application
10.2.1 Middle East and Africa Special Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Special Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Special Injection Market Size by Country
10.3.1 Middle East and Africa Special Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Special Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hengrui
11.1.1 Hengrui Corporation Information
11.1.2 Hengrui Overview
11.1.3 Hengrui Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hengrui Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hengrui Recent Developments
11.2 CSPC
11.2.1 CSPC Corporation Information
11.2.2 CSPC Overview
11.2.3 CSPC Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSPC Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSPC Recent Developments
11.3 Luye Pharma
11.3.1 Luye Pharma Corporation Information
11.3.2 Luye Pharma Overview
11.3.3 Luye Pharma Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Luye Pharma Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Luye Pharma Recent Developments
11.4 Livzon
11.4.1 Livzon Corporation Information
11.4.2 Livzon Overview
11.4.3 Livzon Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Livzon Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Livzon Recent Developments
11.5 Fudan Zhangjiang
11.5.1 Fudan Zhangjiang Corporation Information
11.5.2 Fudan Zhangjiang Overview
11.5.3 Fudan Zhangjiang Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fudan Zhangjiang Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fudan Zhangjiang Recent Developments
11.6 Takeda
11.6.1 Takeda Corporation Information
11.6.2 Takeda Overview
11.6.3 Takeda Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Takeda Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Recent Developments
11.7 Alkemes
11.7.1 Alkemes Corporation Information
11.7.2 Alkemes Overview
11.7.3 Alkemes Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alkemes Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alkemes Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Ipsen
11.9.1 Ipsen Corporation Information
11.9.2 Ipsen Overview
11.9.3 Ipsen Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ipsen Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ipsen Recent Developments
11.10 Sundoc
11.10.1 Sundoc Corporation Information
11.10.2 Sundoc Overview
11.10.3 Sundoc Special Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sundoc Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sundoc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Special Injection Industry Chain Analysis
12.2 Special Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Special Injection Production Mode & Process
12.4 Special Injection Sales and Marketing
12.4.1 Special Injection Sales Channels
12.4.2 Special Injection Distributors
12.5 Special Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Special Injection Industry Trends
13.2 Special Injection Market Drivers
13.3 Special Injection Market Challenges
13.4 Special Injection Market Restraints
14 Key Findings in The Global Special Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Special Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Microsphere Injection
Table 3. Major Manufacturers of Liposome Injection
Table 4. Major Manufacturers of Microemulsion Injection
Table 5. Major Manufacturers of Suspension Injection
Table 6. Global Special Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Special Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Special Injection Sales by Region (2017-2022) & (K Units)
Table 9. Global Special Injection Sales Market Share by Region (2017-2022)
Table 10. Global Special Injection Sales by Region (2023-2028) & (K Units)
Table 11. Global Special Injection Sales Market Share by Region (2023-2028)
Table 12. Global Special Injection Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Special Injection Revenue Market Share by Region (2017-2022)
Table 14. Global Special Injection Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Special Injection Revenue Market Share by Region (2023-2028)
Table 16. Global Special Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Special Injection Sales Share by Manufacturers (2017-2022)
Table 18. Global Special Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Special Injection Revenue Share by Manufacturers (2017-2022)
Table 20. Special Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Special Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Special Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Special Injection as of 2021)
Table 23. Special Injection Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Special Injection Product Offered
Table 25. Date of Manufacturers Enter into Special Injection Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Special Injection Sales by Type (2017-2022) & (K Units)
Table 28. Global Special Injection Sales by Type (2023-2028) & (K Units)
Table 29. Global Special Injection Sales Share by Type (2017-2022)
Table 30. Global Special Injection Sales Share by Type (2023-2028)
Table 31. Global Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Special Injection Revenue Share by Type (2017-2022)
Table 34. Global Special Injection Revenue Share by Type (2023-2028)
Table 35. Special Injection Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Special Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Special Injection Sales by Application (2017-2022) & (K Units)
Table 38. Global Special Injection Sales by Application (2023-2028) & (K Units)
Table 39. Global Special Injection Sales Share by Application (2017-2022)
Table 40. Global Special Injection Sales Share by Application (2023-2028)
Table 41. Global Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Special Injection Revenue Share by Application (2017-2022)
Table 44. Global Special Injection Revenue Share by Application (2023-2028)
Table 45. Special Injection Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Special Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Special Injection Sales by Type (2017-2022) & (K Units)
Table 48. North America Special Injection Sales by Type (2023-2028) & (K Units)
Table 49. North America Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Special Injection Sales by Application (2017-2022) & (K Units)
Table 52. North America Special Injection Sales by Application (2023-2028) & (K Units)
Table 53. North America Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Special Injection Sales by Country (2017-2022) & (K Units)
Table 56. North America Special Injection Sales by Country (2023-2028) & (K Units)
Table 57. North America Special Injection Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Special Injection Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Special Injection Sales by Type (2017-2022) & (K Units)
Table 60. Europe Special Injection Sales by Type (2023-2028) & (K Units)
Table 61. Europe Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Special Injection Sales by Application (2017-2022) & (K Units)
Table 64. Europe Special Injection Sales by Application (2023-2028) & (K Units)
Table 65. Europe Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Special Injection Sales by Country (2017-2022) & (K Units)
Table 68. Europe Special Injection Sales by Country (2023-2028) & (K Units)
Table 69. Europe Special Injection Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Special Injection Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Special Injection Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Special Injection Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Special Injection Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Special Injection Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Special Injection Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Special Injection Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Special Injection Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Special Injection Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Special Injection Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Special Injection Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Special Injection Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Special Injection Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Special Injection Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Special Injection Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Special Injection Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Special Injection Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Special Injection Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Special Injection Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Special Injection Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Special Injection Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Special Injection Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Special Injection Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Special Injection Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Special Injection Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Special Injection Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Special Injection Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Special Injection Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Special Injection Revenue by Country (2023-2028) & (US$ Million)
Table 107. Hengrui Corporation Information
Table 108. Hengrui Description and Major Businesses
Table 109. Hengrui Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Hengrui Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Hengrui Recent Developments
Table 112. CSPC Corporation Information
Table 113. CSPC Description and Major Businesses
Table 114. CSPC Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. CSPC Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSPC Recent Developments
Table 117. Luye Pharma Corporation Information
Table 118. Luye Pharma Description and Major Businesses
Table 119. Luye Pharma Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Luye Pharma Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Luye Pharma Recent Developments
Table 122. Livzon Corporation Information
Table 123. Livzon Description and Major Businesses
Table 124. Livzon Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Livzon Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Livzon Recent Developments
Table 127. Fudan Zhangjiang Corporation Information
Table 128. Fudan Zhangjiang Description and Major Businesses
Table 129. Fudan Zhangjiang Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Fudan Zhangjiang Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Fudan Zhangjiang Recent Developments
Table 132. Takeda Corporation Information
Table 133. Takeda Description and Major Businesses
Table 134. Takeda Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Takeda Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Takeda Recent Developments
Table 137. Alkemes Corporation Information
Table 138. Alkemes Description and Major Businesses
Table 139. Alkemes Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Alkemes Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Alkemes Recent Developments
Table 142. Novartis Corporation Information
Table 143. Novartis Description and Major Businesses
Table 144. Novartis Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Novartis Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Novartis Recent Developments
Table 147. Ipsen Corporation Information
Table 148. Ipsen Description and Major Businesses
Table 149. Ipsen Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Ipsen Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ipsen Recent Developments
Table 152. Sundoc Corporation Information
Table 153. Sundoc Description and Major Businesses
Table 154. Sundoc Special Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Sundoc Special Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sundoc Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Special Injection Distributors List
Table 160. Special Injection Customers List
Table 161. Special Injection Market Trends
Table 162. Special Injection Market Drivers
Table 163. Special Injection Market Challenges
Table 164. Special Injection Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Special Injection Product Picture
Figure 2. Global Special Injection Market Share by Type in 2021 & 2028
Figure 3. Microsphere Injection Product Picture
Figure 4. Liposome Injection Product Picture
Figure 5. Microemulsion Injection Product Picture
Figure 6. Suspension Injection Product Picture
Figure 7. Global Special Injection Market Share by Application in 2021 & 2028
Figure 8. Malignant Tumor Treatment
Figure 9. Diabetes Treatment
Figure 10. Schizophrenia Treatment
Figure 11. Others
Figure 12. Special Injection Report Years Considered
Figure 13. Global Special Injection Sales 2017-2028 (K Units)
Figure 14. Global Special Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Special Injection Revenue 2017-2028 (US$ Million)
Figure 16. Global Special Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Special Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Special Injection Sales Market Share by Region (2023-2028)
Figure 19. North America Special Injection Sales YoY (2017-2028) & (K Units)
Figure 20. North America Special Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Special Injection Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Special Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Special Injection Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Special Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Special Injection Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Special Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Special Injection Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Special Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Special Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Special Injection in the World: Market Share by Special Injection Revenue in 2021
Figure 31. Global Special Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Special Injection Sales Market Share by Type (2017-2028)
Figure 33. Global Special Injection Revenue Market Share by Type (2017-2028)
Figure 34. Global Special Injection Sales Market Share by Application (2017-2028)
Figure 35. Global Special Injection Revenue Market Share by Application (2017-2028)
Figure 36. North America Special Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Special Injection Revenue Market Share by Type (2017-2028)
Figure 38. North America Special Injection Sales Market Share by Application (2017-2028)
Figure 39. North America Special Injection Revenue Market Share by Application (2017-2028)
Figure 40. North America Special Injection Sales Share by Country (2017-2028)
Figure 41. North America Special Injection Revenue Share by Country (2017-2028)
Figure 42. United States Special Injection Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Special Injection Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Special Injection Sales Market Share by Type (2017-2028)
Figure 45. Europe Special Injection Revenue Market Share by Type (2017-2028)
Figure 46. Europe Special Injection Sales Market Share by Application (2017-2028)
Figure 47. Europe Special Injection Revenue Market Share by Application (2017-2028)
Figure 48. Europe Special Injection Sales Share by Country (2017-2028)
Figure 49. Europe Special Injection Revenue Share by Country (2017-2028)
Figure 50. Germany Special Injection Revenue (2017-2028) & (US$ Million)
Figure 51. France Special Injection Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Special Injection Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Special Injection Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Special Injection Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Special Injection Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Special Injection Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Special Injection Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Special Injection Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Special Injection Revenue Share by Region (2017-2028)
Figure 61. China Special Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Special Injection Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Special Injection Revenue (2017-2028) & (US$ Million)
Figure 64. India Special Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Special Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Special Injection Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Special Injection Sales Market Share by Type (2017-2028)
Figure 71. Latin America Special Injection Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Special Injection Sales Market Share by Application (2017-2028)
Figure 73. Latin America Special Injection Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Special Injection Sales Share by Country (2017-2028)
Figure 75. Latin America Special Injection Revenue Share by Country (2017-2028)
Figure 76. Mexico Special Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Special Injection Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Special Injection Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Special Injection Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Special Injection Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Special Injection Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Special Injection Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Special Injection Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Special Injection Revenue Share by Country (2017-2028)
Figure 86. Turkey Special Injection Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Special Injection Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Special Injection Revenue (2017-2028) & (US$ Million)
Figure 89. Special Injection Value Chain
Figure 90. Special Injection Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed


★調査レポート[世界の特殊注射液市場インサイト及び予測(マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液)] (コード:QY22DE18451)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の特殊注射液市場インサイト及び予測(マイクロスフェア注射液、リポソーム注射液、マイクロエマルジョン注射液、懸濁液注射液)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆